Alterations in cancer stem-cell marker CD44 expression predict oncologic outcome in soft-tissue sarcomas

Institutional and national TCGA data show the association of elevated baseline CD44 expression with worse STS outcomes. Further study of CD44 as a possible novel STS biomarker appears indicated.